Sartorius | SRT3 - Net Income


Sartorius reported EUR66.1M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -952K 54K Jun/2026
Avita Medical AUD -7.66M 3.96M Jun/2026
Dianthus Therapeutics USD -50.22M 9.38M Jun/2026
Ionis Pharmaceuticals USD -87M 27.65M Sep/2026
IQVIA Holdings USD 350M 94M Sep/2026
Moderna USD 162M 944M Sep/2026
Organon & Co USD 164M 56M Sep/2026
Revvity USD 62.3M 10.48M Sep/2026
Sartorius EUR 66.1M 200K Sep/2026
Tectonic Therapeutic USD -22.28M 2.96M Jun/2026
Viatris USD -325.3M 206.5M Sep/2026
Xeris Pharmaceuticals USD -31.1M 33.34M Jun/2026